Browse > Article

An RNA Mapping Strategy to Identify Ribozyme-Accessible Sites on the Catalytic Subunit of Mouse Telomerase  

Song, Min-Sun (Department of Molecular Biology, BK21 Graduate Program for RNA Biology, Institute of Nanosensor and Biotechnology, Dankook University)
Lee, Seong-Wook (Department of Molecular Biology, BK21 Graduate Program for RNA Biology, Institute of Nanosensor and Biotechnology, Dankook University)
Publication Information
Genomics & Informatics / v.5, no.1, 2007 , pp. 32-35 More about this Journal
Abstract
Telomerase reverse transcriptase (TERT) is an enzymatic ribonucleoprotein that prolongs the replicative life span of cells by maintaining protective structures at the ends of eukaryotic chromosomes. Telomerase activity is highly up-regulated in 85-90% of human cancers, and is predominately regulated by hTERT expression. In contrast, most normal somatic tissues in humans express low or undetectable levels of telomerase activity. This expression profile identifies TERT as a potential anticancer target. By using an RNA mapping strategy based on a trans-splicing ribozyme library, we identified the regions of mouse TERT (mTERT) RNA that were accessible to ribozymes. We found that particularly accessible sites were present downstream of the AUG start codon. This mTERTspecific ribozyme will be useful for validation of the RNA replacement as cancer gene therapy approach in mouse model with syngeneic tumors.
Keywords
cancer; gene therapy; group I intron; mTERT; RNA replacement; trans-splicing ribozyme; RNA mapping;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hahn, W.C., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks, M.W., and Weinberg, R.A. (1999). Creation of human tumor cells with defined genetic elements. Nature 400, 464-468   DOI   ScienceOn
2 Jones, J.T., Lee, S.W., and Sullenger, B.A. (1996). Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nature Med. 2, 643-648   DOI   ScienceOn
3 Kwon, B.S., Jung, H.S., Song, M.S., Cho, K.S., Kim, S.C., Kimm, K., Jeong, J.S., Kim, I.H., and Lee, S.W. (2005). Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript. Mol. Ther. 12, 824-834   DOI   ScienceOn
4 Lan, N., Rooney, B.L., Lee, S.W., Howrey, R.P., Smith, C.A., and Sullenger, B.A. (2000). Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA. Mol. Ther. 2, 245-255   DOI   ScienceOn
5 Sullenger, B.A. (1995). Revising messages traveling along the cellular information highway. Chem. Biol. 2, 249-253   DOI   ScienceOn
6 Wang, J., Hannon, G.J., and Beach, D.H. (2000). Risky immortalization by telomerase. Nature 405, 755-756   DOI   ScienceOn
7 Long, M.B., Jones, J.P. 3rd, Sullenger, B.A., and Byun, J. (2003). Ribozyme-mediated revision of RNA and DNA. J. Clin. Invest. 112, 312-318   DOI
8 Shi, H.Y., Zhang, W., Liang, R., Abraham, S., Kittrell, F.S., Medina, D., and Zhang, M.(2001). Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res. 61, 6945-6951
9 Ryu, K.J., Kim, J.H., and Lee, S.W. (2003). Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing. Mol. Ther. 7, 386-395   DOI   ScienceOn
10 Jaeger, J., Turner, D., and Zuker, M. (1989). Improved predictions of secondary structures for RNA. Proc. Natl. Acad. Sci. USA 86, 7706-7710
11 Newbold, R.F. (1997). Genetic control of telomerase and replicative senescence in human and rodent cells. Ciba. Found. Symp. 211, 177-189
12 Sullenger, B.A. and Cech, T. R. (1994). Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature 317, 619-622
13 Weitzman, J.B. and Yaniv, M. (1999). Rebuilding the road to cancer. Nature 400, 401-402   DOI   ScienceOn
14 Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S., and Wright, W.E. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352   DOI   ScienceOn
15 Lan, N., Howrey, R.P., Lee, S.-W, Smith, C.A., and Sullenger, B.A. (1998). Ribozyme-mediated repair of sickle ${\beta}$-globin mRNAs in erythrocyte precursors. Science 280, 1593-1596   DOI   ScienceOn
16 Shay, J.W. and Bacchetti, S. (1997). A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791   DOI   ScienceOn
17 Greenberg, R.A., Allsopp, R.C., Chin, L., Morin, G.B., and DePinho, R.A. (1998). Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16, 1723-1730   DOI
18 Song, M.S. and Lee, S.W. (2006). Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme. FEBS Lett. 580, 5033-5043   DOI   ScienceOn